Toxic epidermal necrolysis. A case for the burn intensive care unit;Toxisch epidermale Nekrolyse. Ein Fall für das Schwerverbranntenzentrum

Chirurg

Volumn 74, Issue 5, 2003, Pages 452-460

  Spies, M ^a   Vogt, P M ^a   Herndon, D N ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Burn center; Burn surgery; Diagnosis; Toxic epidermal necrolysis; Treatment strategies

Indexed keywords

BURN; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SENSITIVITY; EXFOLIATION SYNDROME; HUMAN; INTENSIVE CARE UNIT; MEDICAL LITERATURE; MUCOSA; NUTRITIONAL SUPPORT; PAIN; REVIEW; SEPSIS; STATISTICAL MODEL; TOXIC EPIDERMAL NECROLYSIS; WOUND INFECTION; ARTICLE; BANDAGE; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; INTENSIVE CARE; MULTIMODALITY CANCER THERAPY; PATIENT CARE; SKIN TRANSPLANTATION;

BIOLOGICAL DRESSINGS; BURN UNITS; COMBINED MODALITY THERAPY; CRITICAL CARE; DEBRIDEMENT; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; PATIENT CARE TEAM; SKIN TRANSPLANTATION;

EID: 0642346359     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-002-0571-9     Document Type: Review

References (30)

1. Adzick NS, Kim SH, Bondoc CC et al. (1985) Management of toxic epidermal necrolysis in a pediatric burn center. Am J Dis Child 139:499
2. Avakian R, Flowers FP, Araulo OE et al. (1991) Toxic epidermal necrolysis: a review. J Am Acad Dermatol 25:69
3. Becker DS (1998) Toxic epidermal necrolysis. Lancet 351:1417
4. Chasan PE, Hansbrough JF, Cooper ML (1992) Management of cutaneous manifestations of extensive purpura fulminans in a burn unit. J Burn Care Rehabil 13:410
5. Egan CA, Grant WJ, Morris SE et al. (1999) Plasmapheresis as an adjunct treatment to toxic epidermal necrolysis. J Am Acad Dermatol 40:458
6. Freischlag JA, Ajalat G, Busuttil RW (1985) Treatment of necrotizing soft tissue infection: the need for a new approach. Am J Surg 149:751
7. Genoff MC, Hoffer MM, Achauer B, Formosa P (1992) Extremity amputation in meningococcemia induced purpura fulminans. Plast Reconstr Surg 89:878
8. Green RJ, Dafoe DC, Raffin TA (1996) Necrotizing fasciitis. Chest 110:219
9. Guibal F, Bastuji-Garin S et al. (1995) Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 131:669
10. Guillaume JC, Roujeau JC, Revuz J et al. (1987) The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell syndrome). Arch Dermatol 123:1166
11. Halebian PH, Corder VJ, Madden MR et al. (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204:503
12. Lebargy F, Wolkenstein P, Gisselbrecht M et al. (1997) Pulmonary complications in toxic epidermal necrolysis: A prospective clinical study. Intensive Care Med 23:1237
13. Lyell A (1979) Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 100:69
14. McGee T, Munster A (1998) Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Recon Surg 102:1018
15. Mclvor R, Zaidi J, Peters W, Hyland R (1996) Acute and chronic respiratory complications of toxic epidermal necrolysis. J Burn Care Rehabil 17:237
16. Patino JF, Castro D (1991) Necrotizing lesions of soft tissue: areview. World J Surg 15:235
17. Paul C, Wolkenstein P, Adle H et al. (1996) Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis and Stevens-Johnson syndrome. Br J Dermatol 134:710
18. Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB (1987) Management of StevensJohnson syndrome and toxic epidermal necrolysis in children. J Pediatr 115:881
19. Rasmussen JE (1995) Erythema multiforme. Should anyone care about the standards of care? Arch Dermatol 131:726
20. Resnick SD (1992) Staphylococcal toxin-mediated syndromes in childhood. Semin Dermatol 11:11
21. Roujeau JC, Chosidow O, Saiag P, Guillaume JC (1990) Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 23:1039
22. Roujeau JC, Kelly JP, Naldi L et al. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600
23. Ruiz-Maldonado R (1985) Acute disseminated epidermal necrosis type 1,2 and 3: study of sixty cases. J Am Acad Dermatol 13:623
24. Rzany B, Schmitt H, Schöpf E (1991) Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol 71:171
25. Schöpf E, Stühmer A, Rzany B et al. (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 127:839
26. Sheridan RL, Weber JM, Schulz JT et al. (1999) Management of severe toxic epidermal necrolysis in children. J Burn Care Rehabil 20:497
27. Spies M, Sanford AP, Low JFA et al. (2001) Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 108:1162
28. Strom BL, Carson JL, Halpern AC et al. (1991) A population-based study of Stevens-Johnson syndrome: Incidence and antecedent drug exposures. Arch Dermatol 127:831
29. Taylor JA, Grube B, Heimbach DM, Bergman AB (1989) Toxic epidermal necrolysis: A comprehensive approach. Clin Pediatr 28:404
30. Viard I, Wehrli P, Bullani R et al. (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulins. Science 282:490